Fviii + Concizumab Interaction
Majorinteraction on record
Description
High and/or frequent doses increase risk of thromboembolism. Lowest-approved dose recommended for mild to moderate bleeds.
Mechanism
Additive and synergistic increase in thrombin generation
Source: NLP:concizumab